X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BIAF

Closed

Bioaffinity Technologies Inc.

0.263
-0.024 (-8.36%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.2872
Day's Range: 0.255 - 0.289
Send
When Written:
 
1.89
BioAffinity Technologies Inc. is a biotechnology company that develops and commercializes proprietary technologies for the early detection and targeted treatment of cancer. The company's flagship product is the CyPath Lung test, a non-invasive diagnostic test that detects early-stage lung cancer by analyzing sputum samples. BioAffinity Technologies also develops targeted cancer therapies based on its proprietary platform technology, which uses a unique class of molecules called Affinity Peptides to selectively target cancer cells while sparing healthy cells. The company is headquartered in San Antonio, Texas, and is publicly traded on the OTCQB under the ticker symbol "BIOAF."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X